DISEASE DURATION AND HLA-B27 POSITIVITY ALTER LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS

dc.contributor.authorKoca, S. S.
dc.contributor.authorPehlivan, Y.
dc.contributor.authorAkar, S.
dc.contributor.authorSenel, S.
dc.contributor.authorKaradeniz, H.
dc.contributor.authorSosyal, O.
dc.contributor.authorOnen, F.
dc.date.accessioned2026-08-12T18:12:34Z
dc.date.issued2021
dc.departmentFırat Üniversitesi
dc.descriptionAnnual European Congress of Rheumatology (EULAR) -- JUN 02-05, 2021 -- ELECTR NETWORK
dc.description.abstract[Abstract Not Available]
dc.identifier.doi10.1136/annrheumdis-2021-eular.2832
dc.identifier.endpage1317
dc.identifier.issn0003-4967
dc.identifier.issn1468-2060
dc.identifier.orcid0000-0003-4995-430X
dc.identifier.startpage1317
dc.identifier.urihttps://doi.org/10.1136/annrheumdis-2021-eular.2832
dc.identifier.urihttps://hdl.handle.net/11508/63945
dc.identifier.volume80
dc.identifier.wosWOS:000692625300559
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofAnnals of the Rheumatic Diseases
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.titleDISEASE DURATION AND HLA-B27 POSITIVITY ALTER LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS
dc.typeConference Object

Dosyalar